Achyut Healthcare Ltd
BSE:543499
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Achyut Healthcare Ltd
Operating Income
Achyut Healthcare Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Achyut Healthcare Ltd
BSE:543499
|
Operating Income
-₹2.2m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Kretto Syscon Ltd
BSE:531328
|
Operating Income
-₹5.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-20%
|
|
|
B
|
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
|
Operating Income
₹190m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dipna Pharmachem Ltd
BSE:543594
|
Operating Income
₹34.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hemant Surgical Industries Ltd
BSE:543916
|
Operating Income
₹94.5m
|
CAGR 3-Years
19%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Achyut Healthcare Ltd
Glance View
Achyut Healthcare Ltd. engages in the trading of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-03-30. The firm operates in the single business segment of manufacturing pharmaceutical formulations in the forms of tablets, capsules, oral liquids, and injectables. The company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The firm is engaged in the trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium Carbonate Oyster, Cellulose Acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, among many other products. The firm is in the trading business in both domestic as well as international markets in the countries of the United Arab Emirates (UAE), Kenya, and Nigeria.
See Also
What is Achyut Healthcare Ltd's Operating Income?
Operating Income
-2.2m
INR
Based on the financial report for Mar 31, 2025, Achyut Healthcare Ltd's Operating Income amounts to -2.2m INR.
What is Achyut Healthcare Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
-71%
The average annual Operating Income growth rates for Achyut Healthcare Ltd have been -71% over the past three years .
